Brief: Hansoh Pharmaceutical Says China's Nmpa Accepts NDA For Hs-10365 Capsules
23/10/2025 16:05
Oct 23 (Reuters) - Hansoh Pharmaceutical 3692.HK: CHINA'S NMPA ACCEPTS NDA FOR HANSOH'S HS-10365 CAPSULES Further company coverage: 3692.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion